Middle East Healthcare Company

SASE:4009 주식 보고서

시가총액: ر.س6.4b

Middle East Healthcare 미래 성장

Future 기준 확인 5/6

Middle East Healthcare (는) 각각 연간 21.5% 및 10.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 19.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 20.1% 로 예상됩니다.

주요 정보

21.5%

수익 성장률

19.3%

EPS 성장률

Healthcare 수익 성장15.4%
매출 성장률10.3%
향후 자기자본 수익률20.1%
애널리스트 커버리지

Low

마지막 업데이트09 Dec 2024

최근 미래 성장 업데이트

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case

Dec 16
With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case

Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Sep 24
Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

Jul 18
Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

May 30
There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Apr 29
If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

Apr 02
Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Feb 11
There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Feb 08
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Jan 18
Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Dec 28
Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Sep 26
Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Jun 28
Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Mar 30
Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Sep 20
Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Jun 14
Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Apr 18
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Aug 10
Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

Mar 29
Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Mar 03
An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 10
Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

Jan 23
Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Jan 05
If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Dec 18
Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Nov 30
Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

수익 및 매출 성장 예측

SASE:4009 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (SAR Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20274,1044485256923
12/31/20263,7303783034454
12/31/20253,3282941104034
12/31/20242,9292272937062
9/30/20242,854211203665N/A
6/30/20242,793203-23196N/A
3/31/20242,70418269270N/A
12/31/20232,653180-41191N/A
9/30/20232,55117723282N/A
6/30/20232,39313563346N/A
3/31/20232,276105-95172N/A
12/31/20222,15275-17476N/A
9/30/20222,03324-2929N/A
6/30/20222,01927-3091N/A
3/31/20221,96826-259114N/A
12/31/20211,87317-34177N/A
9/30/20211,82345-434-37N/A
6/30/20211,81666-580-160N/A
3/31/20211,73373-501-166N/A
12/31/20201,75182-524-229N/A
9/30/20201,708110-507-182N/A
6/30/20201,603108-348-23N/A
3/31/20201,583104-440-38N/A
12/31/20191,49798-37399N/A
9/30/20191,40191-351133N/A
6/30/20191,35378-335180N/A
3/31/20191,346100-289164N/A
12/31/20181,391172-197159N/A
9/30/20181,445224-39317N/A
6/30/20181,459269N/A204N/A
3/31/20181,464297N/A135N/A
12/31/20171,462319N/A347N/A
9/30/20171,503322N/A370N/A
6/30/20171,529356N/A256N/A
3/31/20171,588368N/A453N/A
12/31/20161,616363N/A253N/A
9/30/20161,629380N/A72N/A
6/30/20161,602371N/A313N/A
3/31/20161,564389N/A303N/A
12/31/20151,535390N/A194N/A
9/30/20151,485373N/A434N/A
6/30/20151,456356N/A383N/A
3/31/20151,431357N/A253N/A
12/31/20141,399332N/A349N/A

애널리스트 미래 성장 예측

수입 대 저축률: 4009 의 연간 예상 수익 증가율( 21.5% )이 saving rate( 14.7% 보다 높습니다. ).

수익 vs 시장: 4009 의 연간 수익( 21.5% ) SA 시장( 6% 보다 빠르게 성장할 것으로 예상됩니다. 6% 연간).

고성장 수익: 4009 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: 4009 의 수익(연간 10.3% ) SA 시장( -0.4% 보다 빠르게 성장할 것으로 예상됩니다. -0.4% 연간).

고성장 수익: 4009 의 수익(연간 10.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 4009 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 20.1 %)

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 현황

데이터마지막 업데이트(UTC 시간)
기업 분석2025/01/02 03:24
장 마감 주가2025/01/02 00:00
수익2024/09/30
연간 수익2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
회사 재무10년
  • 손익 계산서
  • 현금 흐름표
  • 대차 대조표
애널리스트 컨센서스 추정치+3년
  • 재무 예측
  • 애널리스트 목표가
시장 가격30년
  • 주식 가격
  • 배당금, 분할 및 액션
소유권10년
  • 최대 주주
  • 내부자 거래
관리10년
  • 리더십 팀
  • 이사회
주요 개발 사항10년
  • 회사 공지 사항

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Middle East Healthcare Company 12 애널리스트 중 4 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가교육기관
Ibrahim ElaiwatAljazira Capital Company
Jassim Al-JubranAljazira Capital Company
Madhu AppissaAl Rajhi Capital